X-131274112-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001555.5(IGSF1):āc.3846G>Cā(p.Glu1282Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 1,209,788 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 43 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00026 ( 0 hom., 10 hem., cov: 23)
Exomes š: 0.00011 ( 0 hom. 33 hem. )
Consequence
IGSF1
NM_001555.5 missense
NM_001555.5 missense
Scores
1
2
14
Clinical Significance
Conservation
PhyloP100: -0.0410
Genes affected
IGSF1 (HGNC:5948): (immunoglobulin superfamily member 1) This gene encodes a member of the immunoglobulin-like domain-containing superfamily. Proteins in this superfamily contain varying numbers of immunoglobulin-like domains and are thought to participate in the regulation of interactions between cells. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014509708).
BP6
Variant X-131274112-C-G is Benign according to our data. Variant chrX-131274112-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 3108783.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00026 (29/111666) while in subpopulation NFE AF= 0.0000565 (3/53099). AF 95% confidence interval is 0.000015. There are 0 homozygotes in gnomad4. There are 10 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGSF1 | NM_001555.5 | c.3846G>C | p.Glu1282Asp | missense_variant | 19/20 | ENST00000361420.8 | NP_001546.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGSF1 | ENST00000361420.8 | c.3846G>C | p.Glu1282Asp | missense_variant | 19/20 | 1 | NM_001555.5 | ENSP00000355010 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000260 AC: 29AN: 111666Hom.: 0 Cov.: 23 AF XY: 0.000296 AC XY: 10AN XY: 33814
GnomAD3 genomes
AF:
AC:
29
AN:
111666
Hom.:
Cov.:
23
AF XY:
AC XY:
10
AN XY:
33814
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 183366Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67816
GnomAD3 exomes
AF:
AC:
5
AN:
183366
Hom.:
AF XY:
AC XY:
4
AN XY:
67816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000107 AC: 117AN: 1098122Hom.: 0 Cov.: 30 AF XY: 0.0000908 AC XY: 33AN XY: 363478
GnomAD4 exome
AF:
AC:
117
AN:
1098122
Hom.:
Cov.:
30
AF XY:
AC XY:
33
AN XY:
363478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000260 AC: 29AN: 111666Hom.: 0 Cov.: 23 AF XY: 0.000296 AC XY: 10AN XY: 33814
GnomAD4 genome
AF:
AC:
29
AN:
111666
Hom.:
Cov.:
23
AF XY:
AC XY:
10
AN XY:
33814
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;.
MutationTaster
Benign
N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;D;T
Sift4G
Benign
T;T;T;T
Polyphen
P;D;.;P
Vest4
MutPred
0.49
.;Loss of sheet (P = 0.0126);.;.;
MVP
MPC
0.71
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at